Democratizing hedge fund level analysis tools for everyone
Name | Millennium Pharmacon International Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
Pharmaniaga International Corporation Sdn. Bhd. | 73.43 | 73.43 |
Public < 5% | 16.85 | 16.85 |
PT. Danpac Pharma | 9.72 | 9.72 |
Others | 0.01 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Prescription Medicine | 69.0% | 72.5% |
Medical Devices | 25.2% | 21.1% |
Non-prescription Medicine | 5.8% | 6.4% |
Others | 0.0% | 0.0% |
Other | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 0.04 | # 1 / 15 |
EV_EBITDA | 12.87 | # 8 / 15 |
PER | 5.01 | # 1 / 15 |
PBV | 0.54 | # 1 / 15 |
DER | 5.36 | # 13 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | 0.9 | # 10 / 15 |
ROA % | 1.8 | # 10 / 15 |
ROE % | 11.0 | # 9 / 15 |
Year | DPS | Yield [%] |
---|---|---|
2024 | 2.5 | 1.9 |
2023 | 2.0 | 1.3 |
2022 | 1.0 | 0.3 |
2021 | 0.5 | 0.4 |
2020 | 1.0 | 1.0 |
Timeframe | Performance |
---|---|
1W % | -0.8 |
1Mo % | 0.8 |
3Mo % | 1.6 |
1Yr % | 2.4 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
SDPC | 5.01 | 166 B | 1.71 T | 3.89 T | 133 B | 33 B |
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |